Prinses Maxima Centrum voor Kinderoncologie B.V. — Clinical Trial Site

90 Registered trials

49 Currently recruiting

Organisation

Prinses Maxima Centrum voor Kinderoncologie B.V.

Location

Utrecht, Netherlands

Identifier

ORG-100011005

Address

Heidelberglaan 25, 3584 CS, Netherlands

Departments

-
#1101:Kinderoncologie
#9100; Trial and data center
2100:Trial and data center
2200: Pediatric Oncology
3401:Pediatric oncology
Afdeling hematologie
Department of Hemato-oncology
Department of Paediatrics
Department pediatric Hemato-Oncology
Department Solid Tumours
Haemato-oncology
Hemato-oncology
Hematology
Hematology-oncology
Hematooncology
HO
Kinderoncologie
N/A
Neuro-oncologie
Neuro-oncology
Neurooncology
NO
Oncology
Paediatric Oncology
Ped Oncology
Pediatric Hem/Onc
Pediatric hemato-Oncology
Pediatric Hematology/Oncology Department
Pediatric Oncologist
Pediatric Oncology
Pediatrics
Princess Maxima Center for Pediatric Oncology
Prinses Maxima Centrum voor Kinderoncologie
SO
Solid Tumor Department
Solid Tumors
Solid Tumours
Specialisten SO
Stem cell Transplantation and cellular therapy
Supportive Care
Surgery
TDC
Trial and data center
Trial en Data Center
Utrecht Afdeling solide tumoren

Clinical trials at this site (90)

Search interface

ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting

2024-512657-24-00 Acute Lymphoblastic Leukaemia 10 2014-03-27
Glo-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Recruiting

2024-510575-38-00 Relapsed and refractory mature B-cell non-Hodgkin Lymph 10 2026-02-24
A study of belumosudil in children with chronic graft versus host disease (schoolROCK). Recruiting

2024-511508-18-00 Chronic graft versus host disease. 9 2026-01-05
A phase Ib/II first-in-human imaging study of anti-GD2-800CW in patients with neuroblastoma. Recruiting

2023-507596-22-00 Neuroblastoma 7 2025-11-05
INTER-EWING-1: International Clinical Research Programme to Improve Outcomes in Newly Diagnosed Ewing Sarcoma – Trial 1 Recruiting

2024-511989-36-00 Ewing Sarcoma 5 2025-09-24
VyClo ITCC-092 Recruiting

2023-508050-26-00 AML 3 2025-07-17
A clinical study of patritumab deruxtecan (HER3-DXd) in children with cancer (MK-9999-01C) Recruiting

2024-518771-66-00 Hepatoblastoma, Rhabdomyosarcoma 9 2025-07-01
Ziftomenib in combination with chemotherapy for children with relapsed/refractory acute leukemia Recruiting

2023-505262-28-00 Acute Myeloid Leukemia 3 2025-03-24
Phase Ib study combining dinutuximab beta with induction chemotherapy regimens in patients with newly diagnosed high-risk neuroblastoma Recruiting

2023-509673-22-00 Neuroblastoma 9 2024-12-02
Pharmacokinetics of fluconazole given orally or intravenously as prophylaxis or therapy to children and adolescents with invasive fungal inf… Recruiting

2024-518305-17-01 Fungal infection 6 2024-12-02
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
mFBG PET-CT for neuroblastoma Recruiting

2022-501694-39-01 (suspision on) Neuroblastoma 9 2024-11-12
LIGHTBEAM-U01-Substudy 01A: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Pa… Recruiting

2023-507178-41-00 Hematologic Malignancies or Solid Tumors in Pediatric a 9 2024-11-07
International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies … Recruiting

2022-501869-41-00 Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic 9 2023-11-14
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting

2023-504999-25-00 Acute Myeloid Leukemia 5 2023-07-14
68Ga-SATO antagonist in neuroblastoma Recruiting

2024-513843-10-00 neuroblastoma 9 2023-02-28
Study to determine the dose and safety of asciminib in pediatric patients with chronic myeloid leukemia. Recruiting

2023-508129-28-00 Pediatric patients with Philadelphia chromosome positiv 9 2022-09-28
Studying Conditioning Regimen In Pediatric Transplantation -AML Recruiting

2023-505512-37-00 Acute Myeoloid Leukemia 5 2022-06-07
Brigatinib in pediatric and young adult patients with ALK+ ALCL, IMT or other solid tumors (Briga-PED) Recruiting

2024-513412-10-00 Anaplastic Large Cell Lymphoma (ALCL) 9 2022-05-11
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
A Phase 2 Study to Test Effects of Using DAY101 in Children with Brain Cancer Recruiting

2024-510691-20-00 RAF-Altered, Recurrent or Progressive Low-Grade Glioma 4 2021-09-23
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting

2022-501456-28-00 atypical teratoid/rhabdoid tumours (ATRT) 5 2020-07-20
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Acute Lymphoblastic Leukaemia 10 2020-07-13